KDIGO BP Controversies Conference

KDIGO Controversies Conference Blood Pressure in Dialysis Patients

Kidney Disease: Improving Global Outcomes (KDIGO®) hosted a two-day controversies conference on “Blood Pressure in Chronic Kidney Disease Stage 5/ Dialysis Patients” in New York City. Fifty nephrologists, cardiologists, and researchers participated in the conference, which began with plenary session presentations reviewing the newest research on the evaluation, natural history, pathophysiology, and clinical management of blood pressure in patients receiving renal replacement therapy. The presentations were followed by focused discussion groups and a consensus-building process resulting in recommendations that will be published in a position statement.

(Conference Participants)

A primary goal of the conference was to review the quality of the available evidence and make a recommendation to KDIGO on the validity and usefulness of developing a clinical practice guideline in this area.  The group was also asked to determine if consensus could be reached on specific clinical recommendations that could be included in a position statement and,  maybe most importantly, were challenged to outline and prioritize specific research projects that would be most valuable in expanding our knowledge in how to manage blood pressure in CKD Stage 5D.
“What will be the outcome of our gathering?,” asked the KDIGO co-chair and conference leader, Bertram Kasiske, MD during his opening speech. “Will we send a message to clinicians to improve patient outcomes with recommendations, or will we call for more research, or will we decide it is time to update or begin working on a new clinical practice guideline?”

The sessions were moderated by conference co-chairs, Nathan Levin, MD of the Renal Research Institute in New York City and Gérard London, MD of Centre Hospitalier Manhes in Fleury-Mérogis, France.

The full agenda for the conference can be found here. The plenary session presentations included:

Chris Chan, MD

“We are impressed with the focused and productive dialogue that this distinguished group of international experts engaged in during the conference,” said Kai-Uwe Eckardt, KDIGO Co-Chair. “The recommendations that evolved from the discussions will be very valuable for the nephrology community and for the KDIGO Board to consider in planning for future clinical practice guidelines.

Look for the recommendations from the conference to be published in Kidney International in the next year.

The next KDIGO controversies conference will be held in the fall of 2009 to address the topic of “Chronic Kidney Disease: Definition, Classification and Prognosis.”


As a first taster of KDIGO I have been impressed by the organisation, the organisation (the former the body, the latter the "on the ground" component) and above all the spirit in which this meeting was conducted. The fact that it was in one of the few truly great global cities was another special bonus.

Whatever it is eventually decided should come out of the meeting, I would be keen to maintain involvement.

My warmest wishes to all,
Dr David J A Goldsmith

The meeting in NYC was a great experience and I enjoyed our discussions. I am looking forward to the next steps and would like to contribute.
Kind regards,
Hermann Haller

Many thanks for invitation to this excellent meeting. I enjoyed comprehensive lectures, productive discussions and a highly efficient method to develop a consensus statement.

Best regards to all.
Pr Maurice Laville


It was my first experience in a KDIGO controversies conference and I have
really been impressed by the quality of the program, by the efficiency of
the organization and, last but not least, by the open and deep discussion on
the various important issues addressed.
I would be very interested in remaining involved in future KDIGO activities
and in cooperating in the preparation of possible meeting outcomes.

Best Regards,
Gianfranco Parati


I would like to thank KDIGO for undertaking the efforts to organize an international controversies meeting on the much debated issue of blood pressure treatment in CKD5. It is indeed a timely undertaking!

Special thanks to Nathan Levin and Gerard London for putting together this interesting group of experts and the interesting and thought stimulating program and also to the KDIGO chairs Kai-Uwe Eckhardt and Bertram Kasiske for their ongoing activities.

Looking back at the meeting I would like to suggest inviting some experts with a special focus on PD to future meetings on this topic.  
As all the others, I would very much like to keep involved in these issues.

Best wishes,
Martin Kuhlmann

KDIGO, Controversies

New York, NY    
March 14-15, 2009

KDIGO Conference Leaders

Nathan Levin
Conference Co-Chair

Renal Research Institute
New York, USA

Gérard London –
Conference Co-Chair

Centre Hospitalier Manhes
Fleury-Mérogis, France

Bertram Kasiske
KDIGO Co-Chair

Hennepin County Medical Center
Minneapolis, USA

Kai-Uwe Eckardt
KDIGO Co-Chair

University Hospital Erlangen
Erlangen, Germany

KDIGO Conference Attendees

Rajiv Agarwal
Indiana University School of Medicine
Indianapolis, USA

George Bakris          
University of Chicago
Chicago, USA

Ethan Balk    
Tufts-Medical Center
Boston, USA

Gavin Becker
The Royal Melbourne Hospital
Melbourne, Australia

Jeff Berns
University of Pennsylvania
Philadelphia, USA

Peter Blankestijn
University Medical Center
Utrecht, The Netherlands

Michel Burnier
Centre Hospitalier Universitaire
Vaudois Lausanne, Switzerland

Chris Chan          
University Health Network
Toronto, Canada

Charles Chazot   
Centre de Rein Artificiel
Tassin La Demi Lune, France

Alfred Cheung
University of Utah  
Salt Lake City, USA

Adrian Covic
“Dr.C.I.Parhon” University Hospital     
Iaşi, Romania

John Daugirdas
University of Illinois at Chicago School of Medicine
Chicago, USA

Peter de Leeuw
University Hospital Maastricht
Maastricht, the Netherlands

Tevfik Ecder
Istanbul School of Medicine
Istanbul, Turkey

Garabed Eknoyan     
Baylor College of Medicine
Houston, USA

Saraladevi Naicker   
University of the Witwatersrand
Johannesburg, South Africa

Suzanne Oparil    
University of Alabama at Birmingham
Birmingham, USA

Gianfranco Parati      
University of Milano – Bicocca
Istituto Auxologico Italiano
Milan, Itlay

Roberto Pecoits-Filho
Pontifícia Universidade Católica do Paraná
Curitiba, Brazil

Josep Redon       
University of Valencia
Valencia, Spain

Miguel Riella      
Catholic University of Parana
Curitiba, Brazil

Mike Rocco        
Wake Forest University School of Medicine
Winston-Salem, USA

Bernardo Rodriquez-Iturbe  
Hospital Universitario de Maracaibo
Maracaibo, Venezuela

Yunus Erdem       
Hacettepe University School of Medicine
Ankara, Turkey     

Ken Farrington   
Lister Hospital
Hertfordshire, England 

David Goldsmith
Guy's Hospital
London, England

Hermann Haller
Hannover Medical School
Hanover, Germany

Peter Kotanko
Renal Research Institute
New York, USA

Martin Kuhlman
Berlin, Germany

Maurice Laville
Université de Lyon
Lyon, France

Marcel Lebel
Laval University and CHUQ, L’Hôtel-Dieu de Quebec Hospital
Quebec City, Canada

Adeera Levin
St. Paul's Hospital 
Vancouver, Canada

Francesco Locatelli   
A.Manzoni Hospital
Lecco, Italy

Antonio Santoro                                
Università di Bologna
Bologna, Italy

Hiromichi Suzuki 
Saitama Medical University
Saitama, Japan

Jens Titze            
University of Erlangen Nuremberg
Erlangen, Germany

Yusuke Tsukamoto   
Shuwa General Hospital
Saitama, Japan

Nostradola Vaziri      
University of California, Irvine
Orange, CA, USA

Haiyan Wang      
Peking University
Beijing, China

David Wheeler    
The Royal Free and University College Medical School
London, England

Andrzej Wiecek  
Silesian University School of Medicine Katowice, Poland

Volker Wizemann     
Georg-Haas Dialysezentrum
Giessen, Germany

Carmine Zoccali  
CNR-IBIM Clinical Epidemiology of Renal Diseases and Hypertension
Reggio Cal, Italy